Could pressure to make money faster kill the next lifesaving pill?
THE SO WHAT
Activist pressure is shortening drug-development time horizons—R&D portfolios are being optimized for near-term cash, not outlier cures. If you’re building tools for biotech, sell on derisking and capital efficiency for late-stage assets, not on enabling moonshot pipelines.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechWordPress websites under attack — expert report says dozens of plugins hijacked to target thousands of sites
An attacker buying a struggling plugin shop just to ship malware is the new supply-chain risk for the long tail of SaaS and CMS ecosystems. If you're running WordPress or similar, vendor due diligence now includes cap table and ownership changes—not just CVEs.
Deep & Emerging TechPeak Quantum: German Quantum Startup Receives 2.2 Million Euros
€2.2M into Peak Quantum's fault-resistant superconducting chips is another data point that industrial users want hardware tuned for real-world noise, not lab demos. If you're in sectors like chemicals, logistics, or finance, it's time to assign someone to track which quantum stacks are actually targeting your optimization problems.
Deep & Emerging TechHow the Globalstar purchase could turn Amazon’s Leo into a satellite powerhouse
Amazon leaning into Globalstar is a tell that LEO isn't just about broadband—it’s about vertically integrating spectrum, ground, and services into the AWS stack. If your product depends on connectivity in remote or regulated environments, start planning for an Amazon-native satellite option in your architecture and procurement.
Deep & Emerging TechIn vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic
In vivo CAR-T for autoimmune moving into human trials shifts cell therapy from bespoke, ex vivo workflows to something that looks more like a repeatable drug platform. If you’re in healthcare delivery or biotech tooling, assume the bottleneck moves from lab capacity to in-clinic monitoring, data, and safety infrastructure over the next cycle.